PSMB8 and proteosome-associated autoinflammatory syndrome: The designation of PRAAS was first used when a case with compound heterozygous PSMB8 mutations was reported, and then was further applied for the generic name of JMP syndrome, NNS/JASL, and CANDLE syndrome (Fig. 1) [13, 14].